These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 27659526)
1. Acetylation of androgen receptor by ARD1 promotes dissociation from HSP90 complex and prostate tumorigenesis. DePaolo JS; Wang Z; Guo J; Zhang G; Qian C; Zhang H; Zabaleta J; Liu W Oncotarget; 2016 Nov; 7(44):71417-71428. PubMed ID: 27659526 [TBL] [Abstract][Full Text] [Related]
2. Inactivation of androgen-induced regulator ARD1 inhibits androgen receptor acetylation and prostate tumorigenesis. Wang Z; Wang Z; Guo J; Li Y; Bavarva JH; Qian C; Brahimi-Horn MC; Tan D; Liu W Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3053-8. PubMed ID: 22315407 [TBL] [Abstract][Full Text] [Related]
3. ARD1/NAA10 acetylation in prostate cancer. Kuhns KJ; Zhang G; Wang Z; Liu W Exp Mol Med; 2018 Jul; 50(7):1-8. PubMed ID: 30054487 [TBL] [Abstract][Full Text] [Related]
4. HDAC6 regulates androgen receptor hypersensitivity and nuclear localization via modulating Hsp90 acetylation in castration-resistant prostate cancer. Ai J; Wang Y; Dar JA; Liu J; Liu L; Nelson JB; Wang Z Mol Endocrinol; 2009 Dec; 23(12):1963-72. PubMed ID: 19855091 [TBL] [Abstract][Full Text] [Related]
5. Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Fu M; Rao M; Wang C; Sakamaki T; Wang J; Di Vizio D; Zhang X; Albanese C; Balk S; Chang C; Fan S; Rosen E; Palvimo JJ; Jänne OA; Muratoglu S; Avantaggiati ML; Pestell RG Mol Cell Biol; 2003 Dec; 23(23):8563-75. PubMed ID: 14612401 [TBL] [Abstract][Full Text] [Related]
6. Versatility of ARD1/NAA10-mediated protein lysine acetylation. Vo TTL; Jeong CH; Lee S; Kim KW; Ha E; Seo JH Exp Mol Med; 2018 Jul; 50(7):1-13. PubMed ID: 30054464 [TBL] [Abstract][Full Text] [Related]
7. Role of the HSP90-associated cochaperone p23 in enhancing activity of the androgen receptor and significance for prostate cancer. Reebye V; Querol Cano L; Lavery DN; Brooke GN; Powell SM; Chotai D; Walker MM; Whitaker HC; Wait R; Hurst HC; Bevan CL Mol Endocrinol; 2012 Oct; 26(10):1694-706. PubMed ID: 22899854 [TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of HSP90 by protein kinase A is essential for the nuclear translocation of androgen receptor. Dagar M; Singh JP; Dagar G; Tyagi RK; Bagchi G J Biol Chem; 2019 May; 294(22):8699-8710. PubMed ID: 30992362 [TBL] [Abstract][Full Text] [Related]
9. Androgen receptor acetylation site mutations cause trafficking defects, misfolding, and aggregation similar to expanded glutamine tracts. Thomas M; Dadgar N; Aphale A; Harrell JM; Kunkel R; Pratt WB; Lieberman AP J Biol Chem; 2004 Feb; 279(9):8389-95. PubMed ID: 14670946 [TBL] [Abstract][Full Text] [Related]
10. Diverse roles of arrest defective 1 in cancer development. Chaudhary P; Ha E; Vo TTL; Seo JH Arch Pharm Res; 2019 Dec; 42(12):1040-1051. PubMed ID: 31813105 [TBL] [Abstract][Full Text] [Related]
11. The Hsp90 inhibitor, 17-AAG, prevents the ligand-independent nuclear localization of androgen receptor in refractory prostate cancer cells. Saporita AJ; Ai J; Wang Z Prostate; 2007 Apr; 67(5):509-20. PubMed ID: 17221841 [TBL] [Abstract][Full Text] [Related]
12. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells. Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977 [TBL] [Abstract][Full Text] [Related]
13. Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth. Cha TL; Qiu L; Chen CT; Wen Y; Hung MC Cancer Res; 2005 Mar; 65(6):2287-95. PubMed ID: 15781642 [TBL] [Abstract][Full Text] [Related]
14. The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity. Fu M; Rao M; Wu K; Wang C; Zhang X; Hessien M; Yeung YG; Gioeli D; Weber MJ; Pestell RG J Biol Chem; 2004 Jul; 279(28):29436-49. PubMed ID: 15123687 [TBL] [Abstract][Full Text] [Related]
15. FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells. Ni L; Yang CS; Gioeli D; Frierson H; Toft DO; Paschal BM Mol Cell Biol; 2010 Mar; 30(5):1243-53. PubMed ID: 20048054 [TBL] [Abstract][Full Text] [Related]
16. ARD1 contributes to IKKβ-mediated breast cancer tumorigenesis. Zhang Y; Zhou H; Tao Y; Liu X; Yuan Z; Nie C Cell Death Dis; 2018 Aug; 9(9):860. PubMed ID: 30154412 [TBL] [Abstract][Full Text] [Related]
17. ING3 promotes prostate cancer growth by activating the androgen receptor. Nabbi A; McClurg UL; Thalappilly S; Almami A; Mobahat M; Bismar TA; Binda O; Riabowol KT BMC Med; 2017 May; 15(1):103. PubMed ID: 28511652 [TBL] [Abstract][Full Text] [Related]
18. Characterization of Lysine Acetyltransferase Activity of Recombinant Human ARD1/NAA10. Vo TTL; Park JH; Lee EJ; Nguyen YTK; Han BW; Nguyen HTT; Mun KC; Ha E; Kwon TK; Kim KW; Jeong CH; Seo JH Molecules; 2020 Jan; 25(3):. PubMed ID: 32013195 [TBL] [Abstract][Full Text] [Related]
19. Capillarisin blocks prostate-specific antigen expression on activation of androgen receptor in prostate carcinoma cells. Tsui KH; Chang YL; Feng TH; Hou CP; Lin YH; Yang PS; Lee BW; Juang HH Prostate; 2018 Mar; 78(4):242-249. PubMed ID: 29164633 [TBL] [Abstract][Full Text] [Related]
20. Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6. Gibbs A; Schwartzman J; Deng V; Alumkal J Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16663-8. PubMed ID: 19805354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]